EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study

Sudha Kodali, Ashton A Connor, David W Victor, Maen Abdelrahim, Ahmed Elaileh, Khush Patel, Elizabeth W Brombosz, Edward A Graviss, Duc T Nguyen, Susan Xu, Linda W Moore, Mary R Schwartz und 13 weitere

Transplant International · 2026

DOI: 10.3389/ti.2025.15298 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Transplant International, 2026. Verfasst von Sudha Kodali und 24 weiteren Autor:innen. Beteiligte Einrichtung: Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, United States. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixed hepatocellular carcinoma (HCC) with cholangiocarcinoma (HCC-CCA) is an aggressive primary liver cancer and difficult to distinguish from HCC using non-invasive methods. Outcomes of patients incidentally diagnosed with HCC-CCA after LT relative to pure HCC with similar tumor burden were investigated. Medical records of patients undergoing LT (n = 1,898) for HCC (n = 493) from 6/2008–9/2023 were reviewed. Patients incidentally diagnosed with HCC-CCA were propensity matched to HCC patients undergoing LT. Independent analyses were performed using pre-LT (Match1; identifiable pre-LT) and explant pathology (Match2, more prognostic) characteristics. Incidental HCC-CCA occurred in 19 (3.9%) patients; all assumed to have HCC pre-LT and received HCC-directed neoadjuvant treatment. When matched on pre-LT characteristics (Match1, n = 57), more patients with HCC-CCA were outside Milan or University of California, San Francisco criteria on explant (p = 0.01). More patients with HCC-CCA underwent neoadjuvant microwave ablation (p = 0.02) compared to HCC Match2 (n = 45) but were otherwise similar demographically and clinically. Overall and recurrence-free survival were lower for HCC-CCA in Match1 (p = 0.003 and p < 0.001, respectively) and Match2 (p < 0.001 and p = 0.001, respectively). HCC-CCA has an aggressive phenotype with high recurrence after LT. Better screening tools and biomarkers are needed to distinguish HCC-CCA from HCC to ensure patients receive appropriate treatment and maximize post-LT outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularLiver NeoplasmsCholangiocarcinomaBile Duct NeoplasmsHumansFemaleMaleMiddle AgedAgedCohort StudiesRetrospective StudiesIncidental Findings

Stichwörter der Autor:innen

cholangiocarcinomahepatocellular carcinomaliver neoplasmsliver transplantationtransplant oncology

Autor:innen und Institutionen

  • Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, United States.
  • JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, TX, United States.
  • Department of Medicine, Houston Methodist Hospital, Houston, TX, United States.
  • Department of Medicine, Weill Cornell Medical College, New York, NY, United States.
  • Department of Surgery, Houston Methodist Hospital, Houston, TX, United States.
  • Department of Surgery, Weill Cornell Medical College, New York, NY, United States.

Zitieren

APA

Kodali, S., Connor, A. A., Victor, D. W., Abdelrahim, M., Elaileh, A., Patel, K., Brombosz, E. W., Graviss, E. A., Nguyen, D. T., Xu, S., Moore, L. W., Schwartz, M. R., Dhingra, S., Basra, T., Jones-Pauley, M. R., Noureddin, M., Mobley, C. M., Hobeika, M. J., Simon, C. J., …, & Ghobrial, R. M. (2026). Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transplant International. https://doi.org/10.3389/ti.2025.15298

Vancouver

Kodali S, Connor AA, Victor DW, Abdelrahim M, Elaileh A, Patel K, et al. Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transplant International. 2026. doi:10.3389/ti.2025.15298

BibTeX
@article{Kodali2026,
  author = {Kodali, Sudha and Connor, Ashton A and Victor, David W and Abdelrahim, Maen and Elaileh, Ahmed and Patel, Khush and Brombosz, Elizabeth W and Graviss, Edward A and Nguyen, Duc T and Xu, Susan and Moore, Linda W and Schwartz, Mary R and Dhingra, Sadhna and Basra, Tamneet and Jones-Pauley, Michelle R and Noureddin, Mazen and Mobley, Constance M and Hobeika, Mark J and Simon, Caroline J and Lee Cheah, Yee and Heyne, Kirk and Kaseb, Ahmed O and Saharia, Ashish and Gaber, A Osama and Ghobrial, R Mark},
  title = {Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study},
  journal = {Transplant International},
  year = {2026},
  doi = {10.3389/ti.2025.15298}
}
Kostenlos starten →